Hexima scores with DuPont

By Dylan Bushell-Embling
Thursday, 07 August, 2008

Hexima [ASX: HXL] is to partner with chemical multinational DuPont to develop a fungal disease resistance technology in crops such as corn and soybeans.

Under the agreement Hexima and DuPont subsidiary Pioneer Hi-Breed will combine a series of intellectual properties to create the technology. Pioneer will use its gene-shuffling technology while Hexima will offer its gene delivery technology.

Pioneer will own commercialisation rights for corn and soybeans and Hexima will manage all other crops. The first target is broad-spectrum disease resistance in corn, especially stalk rot.

Pioneer has agreed to purchase a five per cent stake in Hexima, or four million shares, at a price of $1.50 per share.

Related News

Quitting smoking increases life expectancy even for seniors

Although the benefits of quitting smoking diminish with age, there are still substantial gains...

Stem cell transplants treat blindness in mini pigs

Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...

Sugary drinks raise cardiovascular disease risk, but occasional sweets don't

Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd